Pharmacy Benefit Managers (PBMs) serve as the critical intermediaries between employers, health plans, drug manufacturers, and pharmacies. Their primary role in employer healthcare costs is to manage prescription drug benefits, negotiate pricing, and control overall pharmacy spending. However, their influence is a double-edged sword: while PBMs can reduce costs through rebates and formularies, their complex pricing models and lack of transparency can sometimes inflate expenses for employers and their employees.
How PBMs Influence Employer Costs
PBMs directly impact employer healthcare costs through several key functions. They negotiate with drug manufacturers for rebates and discounts, create formularies (lists of covered drugs), and manage pharmacy networks. These activities are designed to lower drug prices, but the savings are not always passed through transparently to employers. Let’s break down the mechanics:
1. Rebate Negotiation and Pass-Through
PBMs leverage their large member pools to negotiate rebates from drug manufacturers in exchange for preferred placement on formularies. These rebates can be substantial-sometimes 20-50% of a drug’s list price-and can lower the net cost employers pay. However, the structure is critical:
- Direct pass-through models: Employers receive the full rebate amount, reducing their claims costs.
- Spread pricing models: PBMs charge employers a higher price than they reimburse pharmacies, keeping the difference as profit. This lack of transparency can inflate employer costs.
2. Formulary Design and Drug Tiers
PBMs design formularies to steer utilization toward lower-cost or higher-rebate drugs. This can lower out-of-pocket costs for employees and reduce overall employer spending. Common strategies include:
- Prior authorization for high-cost specialty drugs.
- Step therapy, requiring employees to try cheaper alternatives first.
- Exclusion lists that block certain expensive drugs unless medically necessary.
While these tools control costs, they can also create administrative burdens and limit access for employees with specific medical needs.
3. Pharmacy Network Management
PBMs contract with retail, mail-order, and specialty pharmacies to negotiate reimbursement rates. Employers benefit from lower per-script costs through preferred networks, but PBM-owned pharmacies (like mail-order or specialty) can create conflicts of interest. For instance, a PBM may steer employees to its own mail-order pharmacy, where markups are higher, ultimately costing the employer more than a transparent, independent pharmacy network.
The Transparency Problem
A central issue in PBM’s role is the lack of pricing transparency. Employers often sign contracts that obscure how much they truly pay for a drug versus the PBM’s cost. Key hidden costs include:
- Administrative fees (e.g., per-claim or per-member fees) not tied to drug savings.
- Claim adjudication fees for processing each prescription.
- Spread pricing where the PBM profits undetectably.
This opacity makes it difficult for employers to benchmark PBM performance or compare bids. Recent regulatory scrutiny (e.g., the 2022 PBM Transparency Act) aims to improve disclosure, but many employers still lack full visibility.
Impact on Employee Out-of-Pocket Costs
PBMs also affect how much employees pay at the pharmacy counter. Higher copays or coinsurance can shift costs to workers, especially if PBMs place specialty drugs on high tiers. However, when PBMs secure lower net prices, employers can pass these savings to employees through reduced premiums or copays. The challenge is that PBM incentives sometimes prioritize manufacturer rebates over employee affordability, leading to higher cost-sharing for certain drugs.
Actionable Strategies for Employers
To better manage PBM-related costs, employers should take proactive steps:
- Demand full transparency in contracts (rebate pass-through, administrative fees, and ingredient cost reimbursement).
- Audit PBM performance regularly, using independent consultants to benchmark drug pricing and rebate effectiveness.
- Consider alternative models such as transparent PBMs (e.g., rebate pass-through plus fixed admin fee) or direct contracting with drug manufacturers for high-cost drugs.
- Incorporate PBM contracts into larger benefits strategy, aligning with wellness programs and employee education on generic or biosimilar use.
The Bottom Line
PBMs play a powerful role in employer healthcare costs-they can be strategic allies in cost containment or opaque middlemen adding unnecessary expense. The key is for employers to negotiate contracts with full transparency, hold PBMs accountable for measurable savings, and ensure that employee access and affordability are not sacrificed. By doing so, employers can turn PBM relationships from a cost liability into a vital tool for managing prescription drug spending.